SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after receiving a major analyst upgrade from Rothschild & Co that lifted its price target to $40, fueling community optimism about the company's best-in-class potential in the hidradenitis suppurativa market. Investors are actively discussing the upcoming 40-week long-term data readout at the AAD conference, with many betting that sustained positive clinical results will validate the firm's pipeline and reinvigorate long-standing buyout speculation.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is surging as investors hedge against Middle Eastern geopolitical instability and the resulting threat to global energy supplies, particularly in the European natural gas sector. The stock has become a focal point for the trading community, which is actively discussing its low float, high cost-to-borrow fees, and the potential for a significant short squeeze.

Roma Green Finance Ltd. is a holding company, which engages in the provision of environmental, social and governance, sustainability, and climate change related advisory services through its subsidiaries. Its services include corporate and risk advisory, sustainability strategy services, climate risk advisory, ESG reporting services, and sustainable finance. The company was founded in 2018 and is headquartered in Hong Kong.

Roma Green Finance Ltd - Ordinary Shares - Class A

Roma Green Finance Ltd

Roma Green Finance is seeing increased attention as investors track its recent momentum, with the community actively debating whether the stock is primed for a breakout or remains a volatile candidate for a pump-and-dump. Traders are closely monitoring key support levels and volume patterns, frequently referencing its history of sharp price swings and the speculative potential often associated with small-cap stocks in this sector.

Sysco Corp. engages in the selling, marketing, and distribution of food products to restaurants, healthcare and educational facilities, and lodging establishments. It operates through the following segments: U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other. The U.S. Foodservice Operations segment consists of U.S. Broadline operations, custom-cut meat and seafood companies, FreshPoint, and European Imports. The International Foodservice Operations segment includes operations outside of the United States which distribute a full line of food products and a wide variety of non-food products. The SYGMA segment represents U.S. customized distribution operations serving quick-service chain restaurant customer locations. The Other segment covers hotel supply operations. The company was founded by John F. Baugh in 1969 and is headquartered in Houston, TX.

Sysco Corp.

Sysco is trending as investors weigh strong operational performance and market leadership against ongoing macroeconomic headwinds and a tight labor market. The community is actively debating the company's defensive status, dividend reliability, and the potential impact of its strategic investments in supply chain technology and fleet electrification.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors closely monitor volatility surrounding the company's ambitious 17GW infrastructure project, with active discussions focused on potential tenant announcements, legislative updates, and significant short-term call option activity. Community sentiment remains polarized, as stakeholders weigh the project's long-term potential for powering AI data centers against the risks associated with construction timelines, financing, and recent legal developments.

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Zymeworks BC Inc

Zymeworks Inc

Zymeworks is gaining significant attention after receiving FDA Fast Track Designation for its antibody-drug conjugate ZW191, a key development for treating advanced platinum-resistant ovarian cancer. The community is buzzing over this regulatory milestone, with active discussions focused on the drug's potential as a best-in-class therapy and the company's broader positioning as a high-potential candidate for M&A activity within the oncology sector.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors weigh an upcoming earnings report against significant concerns regarding execution gaps in China, intensifying domestic competition, and a persistent multi-month downtrend. The community is sharply divided, with bulls pointing to historical support levels and insider buying by key executives as a sign of a potential turnaround, while bears highlight consistent technical weakness and structural risks.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets is trending as the community rallies around the recent launch of its token, with active discussions focused on the token's initial growth, upcoming supply burns, and the project's connections to established crypto entities. Investors are heavily debating the project's long-term utility, such as staking and exchange listings, while simultaneously calling for better chart visibility to track the asset's momentum.

CRINGE is a Solana meme token centered around all images, videos, and actions which are cringe!  Warning: Cringe Alert! Remember, folks! Just like we don't judge people based on race, ethnicity, or color, we shouldn't judge them for being cringe. After all, cringe isn't ugly - it's just... special. 😉  Embrace your inner cringe, because in a world full of copycats, being cringey is the new cool!  Meme coins are driven by community, and our community is CRINGE as heck!

CRINGE

CRINGE is trending as community members speculate on its potential for high-percentage gains following a surge in volatility and discussions surrounding its low market capitalization. While some participants express enthusiasm for the asset's rapid price movements, others caution against the speculative nature of such micro-cap tokens, highlighting risks related to market manipulation and volatility.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Gold and Silver Corporation

Americas Gold and Silver is seeing significant community attention driven by a combination of surging silver and antimony prices, alongside the acquisition of the Crescent Mine. Investors are actively debating the stock's potential for a major re-rating as they monitor physical silver supply tightness, the companys internal operational growth, and the broader impact of critical mineral policies on domestic production.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Average Rating of "Moderate Buy" from Brokerages

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twenty-one ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating...

Why Is Cytokinetics (CYTK) Down 0.8% Since Last Earnings Report?

Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

E. Ohman J or Asset Management AB Has $23.06 Million Stock Holdings in Cytokinetics, Incorporated $CYTK

E. Ohman J or Asset Management AB lowered its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) by 10.8% during the fourth quarter, according to its most recent filing with...

Cytokinetics, Incorporated $CYTK Shares Bought by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP lifted its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) by 15.4% during the 3rd quarter, according to its most recent filing with the...

Cytokinetics (NASDAQ:CYTK) EVP Sells $530,885.30 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 8,542 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $62.15, for a total value of $530,885.30. Following the completion of the sale, the executive vice president...

Sung Lee Sells 4,935 Shares of Cytokinetics (NASDAQ:CYTK) Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Sung Lee sold 4,935 shares of the stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total transaction of $306,710.25. Following the sale, the executive vice president directly...

Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells 1,930 Shares of Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 1,930 shares of the firm's stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $62.07, for a total value of $119,795.10. Following the completion of the sale, the executive vice...

Andrew Callos Sells 8,542 Shares of Cytokinetics (NASDAQ:CYTK) Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 8,542 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total transaction of $530,885.30. Following the completion of the sale, the...

Fady Ibraham Malik Sells 12,033 Shares of Cytokinetics (NASDAQ:CYTK) Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 12,033 shares of Cytokinetics stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total value of $747,850.95. Following the sale, the executive...

Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells 36,601 Shares of Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) CEO Robert Blum sold 36,601 shares of the firm's stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total transaction of $2,274,752.15. Following the sale, the chief executive officer...

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$1.64	--	--	N/A
Q4 '25	-$1.56	-$1.50	4.12%	BEAT
Q3 '25	-$1.57	-$2.55	-62.36%	MISSED
Q2 '25	-$1.43	-$1.12	21.66%	BEAT
Q1 '25	-$1.37	-$1.36	0.68%	BEAT

CYTK
Cytokinetics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest CYTK News

CYTKCytokinetics Inc